A detailed history of Man Group PLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Man Group PLC holds 8,776 shares of AMPH stock, worth $399,132. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,776
Holding current value
$399,132
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$38.65 - $43.48 $339,192 - $381,580
8,776 New
8,776 $351,000
Q4 2018

Feb 14, 2019

SELL
$17.72 - $22.51 $326,951 - $415,332
-18,451 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$15.39 - $19.38 $100,896 - $127,055
6,556 Added 55.12%
18,451 $355,000
Q2 2018

Aug 14, 2018

BUY
$14.63 - $19.6 $174,023 - $233,142
11,895 New
11,895 $182,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.23B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.